Ethical concerns relating to the detection and treatment of ovarian cancer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In recent years, research scientists, physicians, and legislators have begun to examine more closely the barriers that women at risk for ovarian cancer run up against in their attempts to get adequate screening and early intervention. In this paper, I discuss two (related) ethical problems that must be confronted by those who respond to these barriers. Both problems stem from an important underlying fact about ovarian cancer. There is no single identifiable cause or marker for this disease. This means that different strategies for combating ovarian cancer will, in all likelihood, have a differential impact on the members of the population who are at risk for this disease. As I show in the paper, this raises important ethical questions about fairness.

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalGynecologic Oncology
Volume84
Issue number1
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Therapeutics
Physicians
Research

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Ethical concerns relating to the detection and treatment of ovarian cancer. / Jansen, Lynn.

In: Gynecologic Oncology, Vol. 84, No. 1, 2002, p. 1-3.

Research output: Contribution to journalArticle

@article{72d57f6b0a4c405fa6cabb9e210bab62,
title = "Ethical concerns relating to the detection and treatment of ovarian cancer",
abstract = "In recent years, research scientists, physicians, and legislators have begun to examine more closely the barriers that women at risk for ovarian cancer run up against in their attempts to get adequate screening and early intervention. In this paper, I discuss two (related) ethical problems that must be confronted by those who respond to these barriers. Both problems stem from an important underlying fact about ovarian cancer. There is no single identifiable cause or marker for this disease. This means that different strategies for combating ovarian cancer will, in all likelihood, have a differential impact on the members of the population who are at risk for this disease. As I show in the paper, this raises important ethical questions about fairness.",
author = "Lynn Jansen",
year = "2002",
doi = "10.1006/gyno.2001.6457",
language = "English (US)",
volume = "84",
pages = "1--3",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Ethical concerns relating to the detection and treatment of ovarian cancer

AU - Jansen, Lynn

PY - 2002

Y1 - 2002

N2 - In recent years, research scientists, physicians, and legislators have begun to examine more closely the barriers that women at risk for ovarian cancer run up against in their attempts to get adequate screening and early intervention. In this paper, I discuss two (related) ethical problems that must be confronted by those who respond to these barriers. Both problems stem from an important underlying fact about ovarian cancer. There is no single identifiable cause or marker for this disease. This means that different strategies for combating ovarian cancer will, in all likelihood, have a differential impact on the members of the population who are at risk for this disease. As I show in the paper, this raises important ethical questions about fairness.

AB - In recent years, research scientists, physicians, and legislators have begun to examine more closely the barriers that women at risk for ovarian cancer run up against in their attempts to get adequate screening and early intervention. In this paper, I discuss two (related) ethical problems that must be confronted by those who respond to these barriers. Both problems stem from an important underlying fact about ovarian cancer. There is no single identifiable cause or marker for this disease. This means that different strategies for combating ovarian cancer will, in all likelihood, have a differential impact on the members of the population who are at risk for this disease. As I show in the paper, this raises important ethical questions about fairness.

UR - http://www.scopus.com/inward/record.url?scp=0036141090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036141090&partnerID=8YFLogxK

U2 - 10.1006/gyno.2001.6457

DO - 10.1006/gyno.2001.6457

M3 - Article

C2 - 11748967

AN - SCOPUS:0036141090

VL - 84

SP - 1

EP - 3

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -